# Letrozole Versus Gonadotropins in Clomiphene Citrate Resistance

> **NCT04834791** · PHASE4 · COMPLETED · sponsor: **Tanta University** · enrollment: 70 (actual)

## Conditions studied

- Clomiphene Citrate Resistance
- Ovulation Induction
- Letrozole
- Gonadotropins

## Interventions

- **DRUG:** Letrozole 2.5mg
- **DRUG:** Gonadotropin

## Key facts

- **NCT ID:** NCT04834791
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-01
- **Primary completion:** 2019-10-31
- **Final completion:** 2019-10-31
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2021-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04834791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04834791, "Letrozole Versus Gonadotropins in Clomiphene Citrate Resistance". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04834791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*